Allergan’s tribal treaty in Restasis patent fight triggers a Congressional donnybrook
Pharma stories have to have a certain colorful quality to swell into a full public scandal. Martin Shkreli had his social media tantrums to keep him radioactive. Mylan was accused of ripping off schools by leveraging vulnerable kids. And now Allergan has the casino-owning Saint Regis Mohawk Tribe as an ally to win the spotlight.
And it’s getting hot under those lights.
Today four powerful Democratic US senators signed off on a scathing letter to the powers that be in Congress, offering a scathing denunciation of Allergan CEO Brent Saunders’ decision to transfer the patents it holds on Restasis to the tribe and then leasing them back on their blockbuster med, all after a $13.75 million payday to shift control to a group with sovereign immunity — which they believe will protect them from an unfair IPR challenge.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.